Urine Test May Improve PCa Diagnosis
ORLANDO—A urine assay for prostate cancer gene 3 (PCA3) is superior to serum PSA tests for predicting outcomes of repeat prostate biopsy, data show.
Prostate And Other Male Cancers
Neoadjuvant PCa Therapy: An Update
In the PSA era, most men with newly diagnosed prostate cancer present with clinically localized disease and are curable with surgery or radiation.
IMRT Shows Promise for PCa Salvage
ORLANDO—Intensity-modulated radiation therapy (IMRT) may offer a promising salvage option for prostate cancer patients who experience PSA relapse following radical prostatectomy, researchers said.
Screening Cuts Risk of Advanced PCa
Biennial PSA screening decreases the likelihood of being diagnosed with metastatic prostate cancer, but nearly doubles the chance of being diagnosed with prostate cancer of any type, a Swedish sudy found.
PSA Velocity A Better Predictor
Preoperative PSA velocity is more useful than PSA doubling time for predicting outcomes after radical prostatectomy for prostate cancer, according to researchers.
Lower PSA Biopsy Threshold Advised
Diagnostic PSA levels in men younger than 50 years are significantly lower than guidelines suggest, according to researchers.
Drug for Baldness Affects PSA Testing
As little as 1 mg/day of finasteride can seriously distort the results of a PSA screening for prostate cancer, a recent study has found.
Lower PSA Biopsy Cutoff Supported
African-American (AA) men with nonpalpable prostate cancer have greater cancer volumes and higher prostatectomy Gleason scores than white men with similar PSA levels at the time of biopsy, according to a study.
Higher PSA Hikes Rescue Failure Risk
PSA levels and PSA doubling time (PSADT) prior to radiotherapy predict outcomes following rescue radiation therapy for men with prostate cancer.
- Loading...
Loading...
Loading... 
Loading...